Legrand‑Herceptin Biosimilar
HER2‑Positive Breast Cancer
CommercialActive
Key Facts
About Laboratorios Legrand
Colombian generics manufacturer accelerating access to affordable medicines across Latin America.
View full company profileTherapeutic Areas
Other HER2‑Positive Breast Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Herceptin (Trastuzumab) Biosimilar | NeuClone | Phase 1 |
| Perjeta (Pertuzumab) Biosimilar | NeuClone | Process Scale‑up |
| MagSense™ HER2 Imaging Agent | Imagion Biosystems | Phase 2 |
| P-003 | Panacea Biotec | Phase 3 |
| Trastuzumab Biosimilar | Hetero | Phase 3 |
| AfriMab-1 | Afrigen Biologics | Preclinical |
| Biosimilar Trastuzumab | Biosidus | Commercial |
| Trazher | Innogene Kalbiotech | Commercial |
| MINC‑trastuzumab | Suntec Medical | Preclinical |